ASAM Supports Expansion of Access to Buprenorphine Through The Mainstreaming Addiction Treatment Act
ASAM Board Member, Dr. Margaret Jarvis, testified in front of a Congressional Roundtable on the nation’s response to the “third…
Advocacy
NYSAM uses its voice and membership to promote public policies that advance addiction medicine and promote access to treatment.
Addiction Medicine Medical Vocabulary
Language Matters We have witnessed remarkable progress in the understanding of the disease of addiction over the past two decades.…
Commentary: Allow Proven Science to Guide Opioid Addiction Treatment
NYSAM board members Dr. Melissa Weimer and Dr. Jeffrey Selzer together with Dr. Daniel Schatz, adjunct assistant professor in the…
Public Policy Action: NYSAM 8987 Senate Bill Response Letter Regarding Marijuana for Treatment of Opioid Use Disorder
On June 11, 2018, the New York State Senate introduced Bill 8987 to amend the public health law in relation…
Public Policy Statement: Substance Use Disorder Treatment for Adults and Adolescents
Introduction Scientific evidence has firmly established that substance use disorders represent a chronic, relapsing disease requiring effective treatment with a…
Public Policy Statement: Strategies to Address the Heroin/Prescription Opioid Epidemic
Strategies to Address the Heroin/Prescription Opioid Epidemic Traditional treatment for opioid addiction has a high failure rate unless the patient…
